Design and implementation of a Pacific intervention to increase uptake of urate-lowering therapy for gout: a study protocol.

ABSTRACT:

Background

Gout is a painful chronic disease which disrupts work and family life and can lead to chronic joint damage. Pacific people in Aotearoa/New Zealand experience significant inequities, with over three times the gout prevalence of the non-Pacific non-Māori populations. Pacific people receive less regular urate-lowering drugs to prevent gout flare-ups, and have nine times the hospitalisation from gout compared with non-Pacific non-Māori people. Rates for Indigenous Māori lie between Pacific and non-Pacific non-Māori. A long-established Collective comprising community members from the Pacific People's Health Advisory Group, clinical staff from the Pacific Practice-Based Research Network, and University of Auckland researchers have identified that improving Pacific urate-loweri

SUBMITTER: Ofanoa M 

PROVIDER: S-EPMC8696972 | biostudies-literature | 2021 Dec

REPOSITORIES: biostudies-literature